These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7200026)

  • 1. Phase I clinical trial with alpha 1,3,5- triglycidyl-s-triazinetrione (NSC-296934).
    Piccart M; Rozencweig M; Dodion P; Cumps E; Crespeigne N; Makaroff O; Atassi G; Kisner D; Kenis Y
    Eur J Cancer Clin Oncol; 1981 Dec; 17(12):1263-6. PubMed ID: 7200026
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase-I study of alpha-1,3,5-triglycidyl-s-triazinetrione (NSC 296934).
    Dombernowsky P; Lund B; Hansen HH
    Cancer Chemother Pharmacol; 1983; 11(1):59-61. PubMed ID: 6883626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hexamethylmelamine (NSC-13875) for acute leukemia and solid tumors in children.
    Dyment PG; Fernbach DJ; Sutow WW
    J Clin Pharmacol New Drugs; 1973; 13(2):111-3. PubMed ID: 4568295
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of the combination of hexamethylmelamine (NSC-13875) and methotrexate (NSC-740) in carcinoma of the lung.
    Weiss AJ; Wilson WL
    Cancer Chemother Rep; 1971 Jun; 55(3):299-302. PubMed ID: 5115850
    [No Abstract]   [Full Text] [Related]  

  • 5. alpha-/beta-Triglycidyl-urazol (TGU, NSC 332488, I.N.N.: ANAXIRONE): a new chemotherapeutic agent.
    Hilgard P; Peukert M; Pohl J
    Cancer Treat Rev; 1984 Jun; 11(2):115-20. PubMed ID: 6498858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I study of two schedules of teroxirone.
    Rubin J; Kovach JS; Ames MM; Moertel CG; Creagan ET; O'Connell MJ
    Cancer Treat Rep; 1987 May; 71(5):489-92. PubMed ID: 3567975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cytostatic treatment of lymphogranulomatosis. Experiences with ibenzmethyzine, cyclophosphamide and vinblastine sulfate].
    Schubert JC; Martin H
    Munch Med Wochenschr; 1968 Jan; 110(2):97-100. PubMed ID: 5695132
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase I trial of teroxirone.
    Neidhart JA; Derocher D; Grever MR; Kraut EH; Malspeis L
    Cancer Treat Rep; 1984 Sep; 68(9):1115-9. PubMed ID: 6478450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and tolerance of Navelbine in phase I-II clinical studies.
    Besenval M; Delgado M; Demarez JP; Krikorian A
    Semin Oncol; 1989 Apr; 16(2 Suppl 4):37-40. PubMed ID: 2540533
    [No Abstract]   [Full Text] [Related]  

  • 10. Phase I trial and pharmacokinetics of trimelamol (N2,N4,N6-trihydroxymethyl-N2,N4,N6-trimethylmelamine).
    Judson IR; Calvert AH; Rutty CJ; Abel G; Gumbrell LA; Graham MA; Evans BD; Wilman DE; Ashley SE; Cairnduff F
    Cancer Res; 1989 Oct; 49(19):5475-9. PubMed ID: 2670205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of camptothecin (NSC-100880) in the treatment of advanced gastrointestinal cancer.
    Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG
    Cancer Chemother Rep; 1972 Feb; 56(1):95-101. PubMed ID: 5030811
    [No Abstract]   [Full Text] [Related]  

  • 12. Vinblastine (NSC-49842) plus vincristine (NSC-67574) given in intensive 3-day courses as therapy for lymphomas, sarcomas, and other neoplasms.
    Stolinsky DC; Bogdon DL; Pugh RP; Braunwald J; Hestorff R; Bateman JR
    Cancer Chemother Rep; 1973; 57(4):481-4. PubMed ID: 4586955
    [No Abstract]   [Full Text] [Related]  

  • 13. Hexamethylmelamine (NSC-13875) in the treatment of advanced cancer.
    Wampler GL; Mellette SJ; Kuperminc M; Regelson W
    Cancer Chemother Rep; 1972 Aug; 56(4):505-14. PubMed ID: 5081594
    [No Abstract]   [Full Text] [Related]  

  • 14. Phase II study of dibromodulcitol (NSC-104800).
    Andrews NC; Weiss AJ; Wilson W; Nealon T
    Cancer Chemother Rep; 1974; 58(5 Pt 1):653-60. PubMed ID: 4426045
    [No Abstract]   [Full Text] [Related]  

  • 15. Phase I and pharmacological studies of pentamethylmelamine administered by 24-hour intravenous infusion.
    Casper ES; Gralla RJ; Lynch GR; Jones BR; Woodcock TM; Gordon C; Kelsen DP; Young CW
    Cancer Res; 1981 Apr; 41(4):1402-6. PubMed ID: 6783296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hexamethylmelamine (NSC-13875) alone and in combination with 5-(3, 3-dimethyl-1-triazeno) imidazole-4-carboxamide (NSC-45388) in the treatment of advanced cancer.
    Stolinsky DC; Bogdon DL; Solomon J; Bateman JR
    Cancer; 1972 Sep; 30(3):654-9. PubMed ID: 5075351
    [No Abstract]   [Full Text] [Related]  

  • 17. [1st experiences in the treatment of ovarian tumors with Peptichemio].
    Natale N; Mangioni C; Remotti G
    Minerva Med; 1974 May; 65(33):1805-10. PubMed ID: 4367233
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase 1 study of carboplatin in patients with advanced cancer, intermittent intravenous bolus, and 24-hour infusion.
    Leyvraz S; Ohnuma T; Lassus M; Holland JF
    J Clin Oncol; 1985 Oct; 3(10):1385-92. PubMed ID: 3900302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II evaluation of 4'-epi-doxorubicin in patients with advanced colorectal carcinoma.
    Michaelson R; Kemeny N; Young C
    Cancer Treat Rep; 1982 Sep; 66(9):1757-8. PubMed ID: 6956441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanistic studies of a novel antitumor drug, alpha-1,3,5-triglycidyl-s-triazinetrione. Antitumor and cytotoxic effects.
    WU FY; Le Pecq JB
    Mol Pharmacol; 1983 Jan; 23(1):182-9. PubMed ID: 6346048
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.